Skip to search formSkip to main contentSkip to account menu

enocitabine

Known as: BH-AC, Docosanamide, N-(1-beta-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-, N(4)-behenoyl ara-C 
A pyrimidine antimetabolite converted to Cytarabine in the body. (NCI)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
We conducted a phase 1 study of a combination of gemtuzumab ozogamicin (GO) plus conventional chemotherapy in elderly patients… 
2009
2009
We investigated the outcome of idarubicin plus N4-behenoyl-1-β-D-arabinofuranosyl cytosine (BHAC)-based chemotherapy (BHAC group… 
2006
2006
This study analysed the clinical outcome of salvage therapy consisting of aclarubicin (ACR) plus behenoyl cytarabine (BHAC) and… 
2000
2000
To clarify the release properties of anti-cancer drugs from fibrin glue, a study was performed using several anti-cancer drugs… 
2000
2000
A multicenter prospective randomized study was undertaken to assess the efficacy of etoposide added to the standard remission… 
1997
1997
Abstract We analyzed the results of treating patients with newly diagnosed acute promyelocytic leukemia (APL) with all-trans… 
1997
1997
We analyzed the results of treating patients with newly diagnosed acute promyelocytic leukemia (APL) with all-trans retinoic acid… 
1987
1987
Winged beans were extracted with hexane and the extracted lipid was analyzed by HPLC for its triacylglycerol (triglyceride…